AstraZeneca (Global Rights to Movantik) Overview
- Status
-
Private
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
AstraZeneca (Global Rights to Movantik) General Information
Description
Global rights to Movantik excluding Europe, Canada and Israel.
Contact Information
Corporate Office
- 1 Francis Crick Avenue
- Cambridge Biomedical Campus
- Cambridge CB2 0AA
- England, United Kingdom
Corporate Office
- 1 Francis Crick Avenue
- Cambridge Biomedical Campus
- Cambridge CB2 0AA
- England, United Kingdom
AstraZeneca (Global Rights to Movantik) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
AstraZeneca (Global Rights to Movantik) Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
AstraZeneca (Global Rights to Movantik) FAQs
-
Where is AstraZeneca (Global Rights to Movantik) headquartered?
AstraZeneca (Global Rights to Movantik) is headquartered in Cambridge, United Kingdom.
-
What industry is AstraZeneca (Global Rights to Movantik) in?
AstraZeneca (Global Rights to Movantik)’s primary industry is Buildings and Property.
-
Is AstraZeneca (Global Rights to Movantik) a private or public company?
AstraZeneca (Global Rights to Movantik) is a Private company.
-
What is the current valuation of AstraZeneca (Global Rights to Movantik)?
The current valuation of AstraZeneca (Global Rights to Movantik) is
. -
What is AstraZeneca (Global Rights to Movantik)’s current revenue?
The current revenue for AstraZeneca (Global Rights to Movantik) is
. -
Who are AstraZeneca (Global Rights to Movantik)’s investors?
HealthCare Royalty Partners has invested in AstraZeneca (Global Rights to Movantik).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »